Search results for "risk factor"

showing 10 items of 4321 documents

Impact of Obesity in Kidney Diseases.

2021

The clinical consequences of obesity on the kidneys, with or without metabolic abnormalities, involve both renal function and structures. The mechanisms linking obesity and renal damage are well understood, including several effector mechanisms with interconnected pathways. Higher prevalence of urinary albumin excretion, sub-nephrotic syndrome, nephrolithiasis, increased risk of developing CKD, and progression to ESKD have been identified as being associated with obesity and having a relevant clinical impact. Moreover, renal replacement therapy and kidney transplantation are also influenced by obesity. Losing weight is key in limiting the impact that obesity produces on the kidneys by reduc…

obesityNutrition and DieteticsNutrition. Foods and food supplybariatric surgeryfatty kidneyReviewurologic and male genital diseasesKidney TransplantationglomerulopathyRisk FactorsCKDHumansTX341-641Kidney DiseasesESRDDialysisFood ScienceNutrients
researchProduct

Innovations in Infant Feeding: Future Challenges and Opportunities in Obesity and Cardiometabolic Disease

2020

The field of nutrition in early life, as an effective tool to prevent and treat chronic diseases, has attracted a large amount of interest over recent years. The vital roles of food products and nutrients on the body’s molecular mechanisms have been demonstrated. The knowledge of the mechanisms and the possibility of controlling them via what we eat has opened up the field of precision nutrition, which aims to set dietary strategies in order to improve health with the greatest effectiveness. However, this objective is achieved only if the genetic profile of individuals and their living conditions are also considered. The relevance of this topic is strengthened considering the importance of …

obesityPediatric ObesityInfants AlimentacióRevieweating behaviorGenetic profile0302 clinical medicineNutrigenomicsPregnancy030212 general & internal medicinePrecision MedicineChildprecision nutritionPediatriaNutrition and DieteticsNutrigenomicsCardiovascular DiseasesChild PreschoolObesitatFemaleDiet HealthyChild Nutritional Physiological Phenomenalcsh:Nutrition. Foods and food supplypediatricsAdolescentNutritional Statuslcsh:TX341-641030209 endocrinology & metabolismChildhood obesityNutrigenetics03 medical and health sciencesEnvironmental healthmedicinemicrobiotaHumansMetabolomicsGenetic Predisposition to DiseaseInfant feedingnutrigeneticsbusiness.industryInfant NewbornInfantFeeding Behaviormedicine.diseaseCardiometabolic diseaseObesitycardiometabolic risk factorsGastrointestinal MicrobiomeFood productsAvaluació del riscbusinessFood ScienceNutrients
researchProduct

Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity

2021

Introduction: The recent global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than 7 million people worldwide and been associated with more than 400,000 deaths. No clear information is known about all the potential risk factors for COVID-19 or what factors adversely influence its clinical course and mortality. Therefore, we analyzed the role of obesity, type 2 diabetes, and hypertension as risk factors for COVID-19. Methods: We identified articles for inclusion by searching PubMed and Google Scholar (last accessed 15 June 2020). Retrospective review of literature. Analysis of epidemiological data co…

obesityhypertensionrisk factordiabeteSARS-CoV-2COVID-19Settore MED/49 - Scienze Tecniche Dietetiche Applicate
researchProduct

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

2013

Small, dense low density lipoprotein (sdLDL) represents an emerging cardiovascular risk factor, since these particles can be associated with cardiovascular disease (CVD) independently of established risk factors, including plasma lipids. Obese subjects frequently have atherogenic dyslipidaemia, including elevated sdLDL levels, in addition to elevated triglycerides (TG), very low density lipoprotein (VLDL) and apolipoprotein-B, as well as decreased high density lipoprotein cholesterol (HDL-C) levels. Obesity-related co-morbidities, such as metabolic syndrome (MetS) are also characterized by dyslipidaemia. Therefore, agents that favourably modulate LDL subclasses may be of clinical value in t…

obesitymedicine.medical_specialtyVery low-density lipoproteinLipoproteinslipid-lowering drugsanti-obesity drugslcsh:TX341-641030209 endocrinology & metabolismReview030204 cardiovascular system & hematologyOverweight03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHigh-density lipoproteinInternal medicineHumansMedicineRisk factorDyslipidemiasMetabolic Syndromeobesity treatmentNutrition and Dieteticssmall dense low density lipoproteinbusiness.industryCholesterollipoproteinmedicine.disease3. Good healthEndocrinologychemistryCardiovascular DiseasesLow-density lipoproteinlipids (amino acids peptides and proteins)Metabolic syndromemedicine.symptombusinesslcsh:Nutrition. Foods and food supplyanti-obesity drugFood ScienceLipoproteinNutrients
researchProduct

Metabolic syndrome

2015

OSA is a common disorder with major cardiovascular and metabolic consequences. OSA is often associated with metabolic syndrome, a cluster of cardiometabolic risk factors, and prevalence of metabolic syndrome is particularly high in OSA patients. The role of obesity as a risk factor for OSA has been shown in population and clinical studies, and increased adipose tissue volume and neck circumference are closely linked with OSA, even though major sex-related differences exist. Besides OSA treatment, cardiometabolic risk factors should be assessed and possibly corrected in all OSA patients in order to reduce adverse events. Occurrence of metabolic syndrome should be investigated, and modifiable…

obesityrisk factorsSettore MED/10 - Malattie Dell'Apparato Respiratorioobstructive sleep apnea
researchProduct

Obesity and diabetes-Not only a simple link between two epidemics

2018

Summary Diabetes (DM) as well as obesity, due to their increasing incidence, were recognized as epidemic by the World Health Organization. Obesity is involved not only in the aetiopathogenesis of the most common worldwide type of DM—type 2 diabetes—but also in the development of its complications. There is also increasing scientific evidence regarding the role of obesity and overweight in type 1 diabetes. Weight gain may be considered as a complication of insulin treatment but also reveals significant pathophysiological impact on various stages of the disease. Another very important aspect related to DM as well as obesity is the microbiome, which is highly variable. The function of the gut …

obesitytype 1 diabetesEndocrinology Diabetes and Metabolismmicrobiome030209 endocrinology & metabolismReview ArticleType 2 diabetesDiseaseOverweightWeight GainBioinformatics03 medical and health sciences0302 clinical medicineEndocrinologyInsulin resistanceRisk Factorsinsulin resistanceDiabetes mellitusInternal MedicinemedicineHumans030212 general & internal medicineMicrobiomeEpidemicsReview ArticlesType 1 diabetesdiabetesbusiness.industrymedicine.diseaseObesityGastrointestinal MicrobiomeDiabetes Mellitus Type 1Diabetes Mellitus Type 2epidemiologytype 2 diabetesmedicine.symptombusinessDiabetes/Metabolism Research and Reviews
researchProduct

Mediating effects of motor performance, cardiorespiratory fitness, physical activity, and sedentary behaviour on the associations of adiposity and ot…

2018

We investigated the associations of cardiometabolic risk factors with academic achievement and whether motor performance, cardiorespiratory fitness, physical activity, or sedentary behaviour mediated these associations. Altogether 175 children 6-8 years-of-age participated in the study. We assessed body fat percentage (BF%), waist circumference, insulin, glucose, triglycerides, HDL cholesterol, and systolic and diastolic blood pressure, leptin, alanine aminotransferase, and gamma-glutamyltransferase (GGT). Reading fluency, reading comprehension, and arithmetic skills were assessed using standardized tests. Speed/agility, balance, and manual dexterity test results were used to calculate moto…

opintomenestysLeptinMaleobesitymedicine.medical_specialtyWaistlapset (ikäryhmät)Physical Therapy Sports Therapy and RehabilitationAcademic achievementBody fat percentage03 medical and health sciences0302 clinical medicinechildrenRisk FactorsHumansMedicineOrthopedics and Sports Medicine030212 general & internal medicineta315Childmetabolinen oireyhtymäExerciseta515AdiposityMetabolic SyndromeAcademic Successbusiness.industryacademic performanceAlanine TransaminaseCardiorespiratory fitnessgamma-Glutamyltransferase030229 sport sciencesmedicine.diseaseObesityfitnessfyysinen kuntoBlood pressureCardiorespiratory FitnessReading comprehensionMotor SkillsPhysical therapylihavuusFemaleInsulin ResistanceSedentary BehaviorMetabolic syndromebusinessJournal of Sports Sciences
researchProduct

Energy Drink Consumption Among Finnish Adolescents: Prevalence, Associated Background Factors, Individual Resources, and Family Factors.

2020

Objectives: Energy drink consumption among adolescents has become a notable global phenomenon, and has been associated with numerous negative health outcomes. In order to understand the popularity of energy drinks among adolescents, and to target interventions, it is important to identify the determinants underpinning consumption. Methods: The nationally representative data (cross-sectional) were drawn from the Health Behaviour in School-aged Children (HBSC) surveys, conducted in 2014 and 2018, each comprising 13- and 15-year-old Finnish adolescents (n = 7405). Results: Weekly energy drink consumption increased among Finnish adolescents between 2014 (18.2%) and 2018 (24.4%), especially amon…

opintomenestysMaleHealth (social science)Adolescentenergy drinkskoulusaavutuksetenergiajuomatterveysosaaminenravitsemuskäyttäytyminennuoretRisk FactorsSurveys and QuestionnairesPrevalenceHumansadolescentsFinlandFamily Characteristicsschool achievementPublic Health Environmental and Occupational Healtheducational aspirationstaustatekijätkotiympäristöSociety Journal Archiveparental monitoringvanhemmatCross-Sectional StudiesSocioeconomic FactorsFemaleOriginal ArticlePublic aspects of medicineRA1-1270health literacyInternational journal of public health
researchProduct

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

1999

Two biallelic polymorphisms in introns 3 and 6 of the p53 gene were analysed for a possible risk-modifying effect for ovarian cancer. Germline DNA was genotyped from 310 German Caucasian ovarian cancer patients and 364 healthy controls. We also typed 124 affected and 276 unaffected female carriers with known deleterious BRCA1 or BRCA2 germline mutation from high-risk breast-ovarian cancer families. Genotyping was based on PCR and high-resolution gel electrophoresis. German ovarian cancer patients who carried the rare allele of the MspI restriction fragment length polymorphism (RELP) in intron 6 were found to have an overall 1.93-fold increased risk (95% confidence internal (CI) 1.27–2.91) w…

p53AdultCancer Researchendocrine system diseasesAdolescentGenotypeGenes BRCA1BiologypolymorphismGermline mutationRisk FactorsGenotypemedicineTumor Cells CulturedHumansAlleleAllele frequencyGerm-Line MutationAgedGeneticsAged 80 and overBRCA2 ProteinOvarian NeoplasmsGenetic Carrier ScreeningCancerGenetic VariationRegular ArticleMiddle Agedmedicine.diseaseBRCA2 ProteinBRCA1Genes p53BRCA2IntronsNeoplasm Proteinsovarian cancerOncologyCase-Control StudiesCancer researchFemaleRestriction fragment length polymorphismOvarian cancergenetic susceptibilityTranscription FactorsBritish Journal of Cancer
researchProduct

Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis.

2003

Inflammation underlies both onset and perpetuation of atherosclerosis. Plasma lipoproteins transport the platelet-activating factor-acetylhydrolase (PAF-AH) with potentially anti-inflammatory activities. Our aim was to determine whether PAF-AH activity was associated with inflammatory markers and with coronary artery disease (CAD). PAF-AH activity and a panel of inflammatory mediators were measured in plasma of 496 patients with CAD and in 477 controls; 276 patients presented with stable angina pectoris and 220 with acute coronary syndrome (ACS). Individuals within the highest quartile of PAF-AH activity had an 1.8-fold increase in CAD risk [95% confidence interval (CI), 1.01 to 3.2; P = 0.…

platelet-activating factorAdultMaleRiskmedicine.medical_specialtyAcute coronary syndromePAF acetylhydrolaseStatinCross-sectional studymedicine.drug_classMutation MissenseInflammationAngiotensin-Converting Enzyme InhibitorsQD415-436Coronary Artery DiseaseBiochemistryCoronary artery diseaseEndocrinologySex FactorsRisk FactorsInternal medicinemedicineHumansAgedInflammationbusiness.industryCell BiologySyndromeMiddle Agedmedicine.diseaseConfidence intervalCross-Sectional StudiesQuartile1-Alkyl-2-acetylglycerophosphocholine EsteraseAcute DiseaseCardiologylipids (amino acids peptides and proteins)Femaleatherosclerosismedicine.symptombusinessJournal of lipid research
researchProduct